Skip to main content

Table 1 Patient demographics

From: The utility of endotracheal aspirate bacteriology in identifying mechanically ventilated patients at risk for ventilator associated pneumonia: a single-center prospective observational study

Baseline variables*

All population (n = 240)

MICU (n = 138)

SICU (n = 102)

p value

Age, yr

63.9 ± 14.8

62.5 ± 14.7

65.9 ± 14.7

0.0752

BMI

30.2 ± 9.5

30.1 ± 9.3

30.4 ± 9.7

0.7875

Hospital LoS

19.6 ± 13.3

16.5 ± 10.4

23.8 ± 15.4

< 0.0001

Duration of MV

9.1** ± 5.1

8.5 ± 5.1

9.8** ± 5.1

0.0482

Male, % (n)

58.8 (141)

58.0 (80)

59.8 (61)

0.7923

All-cause mortality, % (n)

31.3 (75)

39.9 (55)

19.6 (20)

0.0062

SICU, % (n)

42.5 (102)

N/A

N /A

N/A

Emergency surgery, % (n)

30.4 (73)

8.0 (11)

60.8 (62)

< 0.0001

Trauma, % (n)

9.2 (22)

2.9 (4)

17.6 (18)

0.0001

Hypertension, % (n)

50.4 (121)

48.6 (67)

52.9 (54)

0.5165

Diabetes, % (n)

27.5 (66)

29.0 (40)

25.5 (26)

0.5627

Asthma, % (n)

7.5 (18)

8.0 (11)

6.9 (7)

0.8088

COPD, % (n)

17.1 (41)

16.7 (23)

17.6 (18)

0.8636

Chronic heart failure, % (n)

16.3 (39)

19.6 (27)

11.8 (12)

0.1146

Malignancy, % (n)

23.8 (57)

21.0 (29)

27.5 (28)

0.2837

Previous smoker, % (n)

26.7 (64)

26.1 (36)

27.5 (28)

0.8829

Current smoker, % (n)

18.3 (44)

21.7 (30)

13.7 (14)

0.1303

Alcohol abuse, % (n)

23.3 (56)

25.4 (35)

20.6 (21)

0.4416

Antibiotics in the last 90 days, % (n)

43.3 (104)

34.1 (47)

46.1 (47)

0.1774

Antibiotics upon admission, % (n)

15.0 (36)

15.9 (22)

13.7 (14)

0.7161

Immunoactive drugs***, % (n)

22.1 (53)

24.6 (34)

18.6 (19)

0.3450

Admission due to sepsis, % (n)

17.1 (41)

19.6 (27)

13.7 (14)

0.2982

Admission due to respiratory failure or hypoxia, % (n)

27.9 (67)

44.2 (61)

5.9 (6)

< 0.0001

VAP, % (n)

35.4 (85)

31.9 (44)

40.2 (41)

0.2193

S. aureus VAP, % (n)

7.5 (18)

5.8 (8)

9.8 (10)

1.000

Gram-negative VAP, % (n)

7.5 (18)

6.5 (9)

8.8 (9)

0.6215

  1. *Results are presented as mean ± standard deviation for numerical, and as percentage with an absolute count (n) for categorical variables. For comparison of MICU and SICU groups, p-values were determined by unpaired two-tailed t-test for numerical data and two-tailed Fisher’s exact test for categorical data. N/A = not applicable. **1 patient excluded since MV start date was not recorded. ***Including corticosteroids and chemotherapy; upon admission and/or in the last 90 days